510(k) K011710
K011710 is an FDA 510(k) premarket notification submitted by Oxoid , Ltd. for the device "OXOID PBP2 1 LATEX AGGLUTINATION TEST". The FDA issued a decision of Substantially Equivalent on April 2, 2002. The device falls under product code MYI (System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies), a Class II device regulated under 21 CFR 866.1640. Oxoid , Ltd. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- April 2, 2002
- Date Received
- June 4, 2001
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies
- Device Class
- Class II
- Regulation Number
- 866.1640
- Review Panel
- MI
- Submission Type